Contracts

The collaboration will focus on discovering and developing nucleic acid-based immunotherapies for selected oncology targets using Harbour BioMed’s heavy chain only antibody discovery platform (HCAb). HCAb’s technology produces

The platform of Refuge is a synthetic biology system leveraging an expression modulation strategy to repress or activate transcription of target genes. Early pre-clinical data indicate a potential

Under the terms of the deal, the company will be responsible for the supply of 100,000 doses of the vaccine. The company will seek regulatory approval of the

Under the terms of the deal, the company will facilitate access to its monkeypox vaccines in Latin America and the Caribbean, as well as the countries that participate

Under the terms of the deal, the company will be responsible for the supply of 2.5 million additional doses of liquid frozen Jynneos vaccines. The latest move follows

The drug is approved and available in the US and Europe to treat partial-onset seizures in adults. As per the terms of the agreement, SK Biopharmaceuticals has granted

The company is a joint venture between WuXi Biologics and WuXi STA and provides end-to-end contract research, development, and manufacturing of bioconjugates, such as ADCs. Under the terms

This agreement will allow Quoin to offer healthcare professionals and patients in greater China, including Hong Kong, Macau and Taiwan, with access to its products following receipt regulatory

With over a hundred years of experience, Intravacc is a contract development and manufacturing organization (CDMO) of vaccines against infectious diseases. A vaccine company in China, Zhifei Lvzhu